North America Internal Neuromodulation Market 2019

The North American neuromodulation market is expected to reach $4,854.4 million by 2019 at a CAGR of 10.5% from 2014 to 2019. Neuromodulation is defined as the use of technology to regulate the nervous system involving various processes, such as therapeutic alteration, stimulation, modification, inhibition, and others for the proper functioning of the body.

This is carried out with the help of implantable devices. These devices are usually neural stimulators, which are used to treat various chronic and acute pain syndromes, dystonia, movement disorders, and spasticity.

Read full report: https://www.globalmarketreports.com/north-america-internal-neuromodulation-market-by-type-spinal-cord-deep-brain-sacral-nerve-vagus-nerve-gastric-neuro-stimulator-application-parkinsons-disease-chronic-pain-analysis-and-forecast-to-2019-23965

There are various types of stimulators that are usually used to stimulate the spinal cord and brain. The types include spinal cord stimulator, deep brain stimulator, gastric electrical stimulator, vagus nerve stimulator, and sacral nerve stimulator. The North America neuromodulation market has been segmented by procedure, modality, and geography.

On the basis of procedure, the market is further segmented into internal and external stimulation.

The internal stimulation segment accounted for a higher market share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality.

About Global Market Reports

Global Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 100,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 19 Bethlehem Road

Bethlehem, Tauranga

New Zealand 3110

Email: sales@globalmarketreports.com

Phone:...